NCT02527603

Brief Summary

To compare the results and efficacy of the self-assisted Boss-Holzach-Matter maneuver for anterior shoulder dislocation and the Spaso method performed by a physician.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

August 15, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 19, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2017

Completed
Last Updated

March 21, 2017

Status Verified

March 1, 2017

Enrollment Period

1.6 years

First QC Date

August 15, 2015

Last Update Submit

March 20, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change From Baseline in Pain that the patient experiences during the reduction procedure

    Pain the patient feels during the reduction maneuver. The patient will be asked after reduction to fill out a form with a analog visual scale with scores ranging from 0 \[no pain\] to 10 \[worst possible pain\].

    Patients will be assessed throughout their visit to the Trauma Unit. No further following should be necessary.There will be no change in pain measurement, only the amount of pain felt during the manoeuvre.

Study Arms (2)

Spaso Method

EXPERIMENTAL

Randomized for Sp method + 1 initial dose of 50mg dexketoprofen IM or 25mg Oral

Procedure: Spaso methodDrug: Anti-Inflammatory Agents, Non-Steroidal

Boss-Holzach-Matter Method

EXPERIMENTAL

Randomized for BHM method +1 initial dose of 50mg dexketoprofen IM or 25mg Oral

Procedure: Boss-Holzach-Matter methodDrug: Anti-Inflammatory Agents, Non-Steroidal

Interventions

The patient holds both his hands around his knees in a supine position until the dislocated shoulder is reduced

Also known as: Self-assited Method
Boss-Holzach-Matter Method
Spaso methodPROCEDURE

The physician holds the dislocated arm of the patient in a supine position and proceeds with gentle, soft movements of adduction, flexion and external rotation of the limb in this order until reduction is accomplished.

Spaso Method

All patients will be administered a dose of NSAI intra-muscular or orally ("Dexketoprofen", "Enantyum®") it is part of the normal treatment of these patients to cope with pain.

Also known as: Pain Killer, "Enantyum®"
Boss-Holzach-Matter MethodSpaso Method

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with an acute anterior shoulder dislocation that are diagnosed in our hospital trauma area.

You may not qualify if:

  • Fracture luxation of the same shoulder.
  • Inability to cooperate due to mental or physical condition.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Corporación sanitaria Parc Taulí de Sabadell

Sabadell, Barcelona, 08208, Spain

Location

MeSH Terms

Conditions

Shoulder Dislocation

Interventions

Anti-Inflammatory Agents, Non-Steroidaldexketoprofen trometamol

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesShoulder Injuries

Intervention Hierarchy (Ancestors)

Analgesics, Non-NarcoticAnalgesicsSensory System AgentsPeripheral Nervous System AgentsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesAnti-Inflammatory AgentsTherapeutic UsesAntirheumatic Agents

Study Officials

  • David Marti, PhD

    Doctor

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

August 15, 2015

First Posted

August 19, 2015

Study Start

August 1, 2015

Primary Completion

March 1, 2017

Study Completion

March 1, 2017

Last Updated

March 21, 2017

Record last verified: 2017-03

Locations